Category: Life Sciences
Life Sciences
Danish pharmaceutical firm LEO Pharma has reportedly announced a strategic development and commercialization partnership with the California-based PellePharm to advance research of therapies utilized to treat rare skin disorders. As per the terms of the deal, LEO Pharma would initially commit USD 70 million, consisting …
Life Sciences
The Singapore National Eye Center and the Singapore Eye Research Institute along with Johnson & Johnson Vision have reportedly formed a research collaboration worth $26.35 million to tackle myopia. As per credible sources, half of the world’s population is projected to be myopic by 2050, …
Life Sciences
Indian pharmaceutical giant Cipla has confirmed that it has been granted the final approval by the United States Food and Drug Administration (USFDA) for its Valganciclovir tablets which are used in treating viral eye infections in AIDS patients. According to Cipla, the drug is used …
Life Sciences
Pharmaceutical behemoth Merck & Co. Inc. has reportedly ended its longstanding agreement to supply a lifesaving vaccine to children in West Africa. Concurrently, the company has begun trading sending vaccines to China, where it will be sold for a higher price. The vaccine prevents rotavirus, …
Life Sciences
Eagle Genomics, a life sciences smart data management and analysis company known for pioneering the microbiome data platform, has reportedly announced to have teamed up with Microsoft Genomics to collaborate in the field of microbiome genomics. Microsoft Genomics is a Microsoft Azure service that is …
Life Sciences
Palette Life Sciences AB, a fully-integrated life sciences company has recently entered into a definitive agreement with skin care firm, Nestlé Skin Health to license worldwide commercialization and development rights for Solesta®, Deflux®, and Barrigel™ medication. As per trusted sources, the transaction would effectively create …
Life Sciences
Trevena Inc., – a clinical-stage biopharmaceutical company from Pennsylvania has reportedly announced that it has failed to obtain an approval from the U.S. Food and Drug Administration advisory panel. Reports cite, the advisory panel on October 11th, 2018 voted against the approval of Trevena’s opioid …
Life Sciences
Rgenix – a New York-based clinical-stage biopharmaceutical company has reportedly announced that it has raised approximately $40 million in series C funding to execute early as well as mid-stage clinical trials to advance a couple of cancer medications. Reports cite, one of the two cancer …
Life Sciences
Australian biotech Immutep has reportedly announced a clinical trial collaboration and supply agreement with pharma heavyweights Merck and Pfizer. As per trusted sources, the terms of the deal include tests of Immutep’s drug candidates known as eftilagimod alpha, also called as IMP321 or efti. The …